107479-55-0

Basic information

• Product Name: 7-CHLORO-2,3,4,5-TETRAHYDRO-1H-BENZO[E][1,4]DIAZEPINE
• Synonyms: 1H-1,4-Benzodiazepine, 8-chloro-2,3,4,5-tetrahydro-
• CAS NO: 107479-55-0
• Molecular Formula: C9H11ClN2
• Molecular Weight: 182.06
• Mol File: 107479-55-0.mol
• Article Data: 2

Chemical Properties

• Boiling Point: 309.944 °C at 760 mmHg
• Flash Point: 141.25 °C
• Appearance: /
• Density: 1.156 g/cm³
• Vapor Pressure: 0.001mmHg at 25°C
• Refractive Index: 1.546
• PKA: 8.84±0.20(Predicted)
• CAS DataBase Reference: 7-CHLORO-2,3,4,5-TETRAHYDRO-1H-BENZO[E][1,4]DIAZEPINE(CAS DataBase Reference)
• NIST Chemistry Reference: 7-CHLORO-2,3,4,5-TETRAHYDRO-1H-BENZO[E][1,4]DIAZEPINE(107479-55-0)
• EPA Substance Registry System: 7-CHLORO-2,3,4,5-TETRAHYDRO-1H-BENZO[E][1,4]DIAZEPINE(107479-55-0)

Safety Data

• Hazardous Substances Data: 107479-55-0(Hazardous Substances Data)

Usage

Description

7-Chloro-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepine, a heterocyclic compound with the molecular formula C11H12ClN, features a seven-membered ring composed of four carbon atoms, one nitrogen atom, and two double bonds. 7-CHLORO-2,3,4,5-TETRAHYDRO-1H-BENZO[E][1,4]DIAZEPINE is a tetrahydrobenzodiazepine, a class of psychoactive drugs known for their sedative and anxiolytic properties. The presence of a chloro group attached to the benzene ring endows it with a chlorine atom, making it a subject of interest for further research and potential medical applications, particularly in the treatment of central nervous system disorders and mental health conditions.

Uses

Used in Pharmaceutical Industry:
7-Chloro-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepine is used as a potential therapeutic agent for the treatment of central nervous system disorders and mental health conditions. Its molecular structure and properties make it a promising candidate for further research and development in the field of psychopharmacology.
Used in Research and Development:
7-Chloro-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepine serves as a valuable compound for scientific research, particularly in the study of the structure-activity relationships of benzodiazepines and their potential applications in medicine. Its unique molecular features provide insights into the design and synthesis of novel psychoactive drugs with improved efficacy and safety profiles.

InChI:InChI=1/C9H11ClN2/c10-8-2-1-7-6-11-3-4-12-9(7)5-8/h1-2,5,11-12H,3-4,6H2

Upstream product

• 195983-60-9 8-chloro-3,4-dihydro-1H-benzo[e][1,4]diazepine-2,5-dione 

Relevant articles and documents

Inhibitors of farnesyl protein transferase

The present invention comprises benzodiazepine compounds having farnesyl transferase inhibitory activity.